Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Site Directed Mutagenesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108690836B details a mutated cyclohexanone monooxygenase for high-conversion esomeprazole synthesis, offering superior purity and scalability for API manufacturers.
Patent CN116574707B reveals high-activity LeuDH mutant for L-tert-leucine. Enables cost reduction in pharmaceutical intermediates manufacturing with high purity.